Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · May 29, 2024

Biological Therapies for Inverse or Vulgar Psoriasis: Therapeutic Effects of Anti–IL-23 and Anti–IL-17 Agents

International Journal of Dermatology


Additional Info

International Journal of Dermatology
Clinical characteristics and response to biological therapies for inverse psoriasis: a real-life comparison between the therapeutic effects of anti-IL-23 and anti-IL-17 agents
Int. J. Dermatol 2024 May 15;[EPub Ahead of Print], L Mastorino, P Dapavo, N Macagno, M Ortoncelli, A Verrone, E Stroppiana, C Cariti, S Susca, N Siliquini, IG di Corteranzo, P Quaglino, S Ribero

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading